Dahms Bradford D. has filed 3 insider transactions across 1 company since July 2025.
Most recent transaction: a grant/award of 37813 shares of Jade Biosciences, Inc. ($JBIO) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Jade Biosciences, Inc. | $JBIO | Dahms Bradford D. | Chief Financial Officer | A | Common Stock | 37813 | $0.00 | 37,813.0000 | 46,004,205 | 9999.99% | 0.08% |
| Feb. 12, 2026 | Jade Biosciences, Inc. | $JBIO | Dahms Bradford D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 226875 | $0.00 | 226,875.0000 | 46,004,205 | 9999.99% | 0.49% |
| July 14, 2025 | Jade Biosciences, Inc. | $JBIO | Dahms Bradford D. | Chief Financial Officer | A | Stock Option (Right to Buy) | 526000 | $0.00 | 526,000.0000 | 0 | 9999.99% | 0.00% |